000			03465nam a2200445 i 4500
999			_c394245 _d394245
001			394245
003			ES-MaUEC
005			20230102123112.0
006			a||||fo|||| 00| 0
007			cr nn 008mamaa
008			221022s2022 sz a o |||| 0|eng d
020			_a9783031100901
024	7		_a10.1007/978-3-031-10090-1 _2doi
040			_aES-MaUEC _bspa _cES-MaUEC _dES-MaUEC
050		4	_aRC270.3.T65 _b2022 EB
245	0	0	_aArtificial Intelligence in PET/CT Oncologic Imaging _cedited by John A. Andreou, Paris A. Kosmidis, Athanasios D. Gouliamos
250			_a1st edition 2022
264		1	_aCham _bSpringer International Publishing _c2022
300			_a1 recurso en línea (XIV, 151 páginas) _b27 ilustraciones, 24 ilustraciones a color
336			_atexto _btxt _2rdacontent
337			_aelectrónico _bc _2rdamedia
338			_arecurso electrónico _bcr _2rdacarrier
347			_aarchivo de texto _bPDF
505	0		_a1. Introduction : Artificial intelligence (AI) systems for Oncology -- 2. PET in Bone and Soft tissue tumors -- 3. (CNS) PET/CT: current AI applications -- 4. PET/CT findings in Head and Neck Cancer, current AI applications -- 5. PET/CT in Lung cancer, current AI applications -- 6. Breast cancer: PET/CT imaging, AI applications -- 7. PET/CT in Gynecologic cancer, current AI applications -- 8. PET/CT in Rectal cancer, current AI applications -- 9. PET/CT in Neuroendocrine tumors, current AI applications -- 10. PET/CT in the evaluation of Adrenal gland mass -- 11. PET/CT in Renal cancer -- 12. PET/CT in Testicular cancer -- 13. PET/CT in Prostate cancer -- 14. PET/CT in Malignant Lymphomas.
520			_aThis book presents artificial intelligence applications that may help in detecting disease, defining tissue characterization (benign vs malignant), staging and correlation with molecular biomarkers. Originally positioned as a means for noninvasive molecular phenotyping and quantification in the 1970s, PET's technological improvements in the 2000s generated renewed interest in quantification, which has grown over the last five years. This progress is parallel with the development of Artificial intelligence (AI) systems for Oncology which aim at providing the best possible treatment to patients suffering from lung, breast, brain, prostate, liver and other types of cancer. The chapters provide an overview of the use of AI in PET/CT imaging for various types of cancer, and it will be an invaluable tool especially for nuclear medicine physicians and oncologists.
988			_aSpringer_Medicine_2022
650		7	_2embne _9392696 _aCáncer _xTomografía
650		7	_2embne _9421371 _aInteligencia artificial en medicina
700	1		_aAndreou, John A _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt
700	1		_aKosmidis, Paris A _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt
700	1		_aGouliamos, Athanasios D _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt
776	0	8	_iPrinted edition: _z9783031100895
776	0	8	_iPrinted edition: _z9783031100918
776	0	8	_iPrinted edition: _z9783031100925
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-031-10090-1 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942			_2lcc _cLE
998			_b12/2022 _dz _eb _zSI